Abnormal glucose tolerance and lipid abnormalities in Indian myocardial infarct survivors by Sewdarsen, M. et al.
238 SA MEDIESE TYDSKRIF DEEL 63 12 FEBRUARIE 1983
Abnormal glucose tolerance and lipid
abnormalities in Indian myocardial
infarct survivors
M. SEWDARSEN, I. JIALAL, S. VYTHILlNGUM
Date received: 3 May 1982.
Summary
Ischaemic Heart Disease Clinic, Department of Medicine,
R. K. Khan Hospital, and Departments of Chemical Patho-
logy and Cardiology, University of Natal, Durban
M. SEWDARSEN, M.B. CH.B.
I. JIALAL, M.B. CH.B.
S. VYTHILINGUM, M.B. CH.B., M.R.C.P.
The high incidence of CAD and its accompanying mor:rality in
the South Mrican Indian population have been highlighted by
previous workers.7•s It has previously been shown that.:the fre-
quency of abnormal glucose tolerance (impaired glucose tole-
rance and diabetes mellitus) in Indian patients with CAD is
similar to that in White patients. 9 However, with respect to the
lipid profile there have been conflicting reports; hypercholeste-
rolaemia was present in 37% of the series described by McKech-
nie' and Davidson,lo whilt; Thandroyen et al. 9 have reported
hypercholesterolaemia in 63% of their Indian patients. No study
has compared lipid levels in healthy Indian controls with those in
CAD survivors, nor have there been any reports on HDL
cholesterol levels in Indian patients with CAD.
This study was therefore undertaken to assess the status of
lipid aberrations with respect to fasting plasma cholesterol, tri-
glyceride and HDL cholesterol values and abnormal glucose
tolerance (impaired glucose tolerance and diabetes mellitus) in




The patients selected for this study were 103 Indian subjects
attending the Ischaemic Heart Disease Clinic at the R. K. Khan
Hospital, Durban. All had had at least one acute myocardial
infarction (MI). The criteria for the diagnosis of MI were a
history of chest pain supported by unequivocal electrocardio-
graphic findings of abnormal Q waves and raised ST segments
and/or sequential ST-T -wave changes, accompanied by a tran-
sient rise in aspartate amino transferase, lactate dehydrogenase
and creatine kinase levels. The MI was presumed to be due to
coronary atherosclerosis.
The patients (96 males and 7 females) were matched as regards
age and sex with a control group of apparently healthy Indian
hospital staff numbers. Informed consent was obtained from all
the participants in the study.
Methods
In all cases investigations were carried out a minimum of 3
months after MI. The specimens for lipid analyses were taken
after a 14-hour fast according to the precautions set out by
Lewis." Mter centrifugation, the sera were stored at 4°C and
assays were undertaken within 3 days. Cholesterol and triglyce-
rides were measured by enzymatic methods, utilizing commer-
cial kits (Boehringer Mannheim, GmBH Diagnostica). A control
serum sample was included in each assay (Preclip). HDL choles-
terollevels were measured by a polyanion precipitation method,
using phosphomngstic acid and magnesium chl«;lride. 12 Serum
cholesterol levels above 6,5 rnmoVl and triglyceride levels above
2,0 mmoVl were arbitrarily defmed as abnormal, according to
the criteria of Stamler et al. 13
Oral glucose tolerance tests were performed on all patients
except those who were already known to have diabetes. The
Hyperlipidaemia l and hyperglycaemia2 have long been impli-
cated in the pathogenesis of coronary artery disease (CAD).
Whereas hypercholesterolaemia and hyperglycaemia are well-
recognized risk factors for the development of CAD, the rela-
tionship between hypertriglyceridaemia3 and CAD is less well
defined. Recently a further risk factor has emerged; an inde-
pendent inverse relationship between high-density lipoprotein
(HDL) cholesterol and CAD, which has been established by
many studies.4•5 The relative frequency of these risk factors
varies geographically and among different racial groupS.6
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Glucose tolerance and lipid levels in a random sam-
ple of 103 Indian patients (96 males and 7 females)
with coronary artery disease (CAD) aged between
20 and 55 years were compared with those in a
healthy Indian control group matched as regards
age and sex. Previous episodes of myocardial infarc-
tion were taken as evidence of CAD. Of tne patients
44% were overweight:
Glucose tolerance was abnormal in 55% of the
patients. Both cholesterol and triglyceride values in
the patients withCAD were significantly higher than
those in the control group. Serum cholesterol levels
were over 6,5 mmol/I in 62% of the patients with
CAD and serum triglyceride levels were over 2,0
mmol/I in.53%. Males with CAD tended to have
lower plasma high-density lipoprotein. (HDL) cho-
lesterollevels than the control group (P < 0,01).
There was a significant negative correlation
between body mass index and HDL cholesterol, and
no correlation was demonstrated between b.ody
mass index and total cholesterol or triglyceride le-
vels. Furthermore, when the patients were sub-
grouped according to their glucose tolerances it
was found that only the triglyceride levels were sig-
nificantly different (values were higher in those with
abnormal glucose tolerance). Our data~suggestthat
abnormal glucose tolerance and lipid aberrations
are significant risk factors in Indian patients with
CAD.
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TABLE 11. LIPID LEVELS IN MALE MI SURVIVORS
Controls MI survivors
diagnosis of diabetes mellitus and impaired glucose tolerance
was based on 1980 World Health Organization criteria: diabetes
was considered to be present if the fasting plasma glucose level
was ;:. 8 mm01l1 and/or the 2-hour plasma glucose level after a
50 g oral glucose load;:' 10 mm01l1; impaired glucose tolerance
was diagnosed if the fasting plasma glucose level was < 8 mmol/l
and the 2-hour plasma glucose level after a 50 g oral glucose load
;:. 8 and < 10 mmol/1. All the controls had fasting plasma glucose
levels of < 6 mm01l1.
Body mass indices were calculated according to Bray.14 Males
with a body mass index of;:' 25 and females with a body mass
index of;:' 27 were considered to be overweight. 15 Lipid levels
were compared using the Mann-Whitney U test. Correlation
coefficients between variables were also calculated. All data are























TABLE Ill. LIPID LEVELS IN FEMALE MI SURVIVORS
Results
One hundred and eighty-four subjects between the ages of 20
and 55 years panicipated in the study; 103 (96 males and 7
females) were MI survivors and the rest (74 males and 7 females)
were healthy controls. Mean ages and body mass indices of the
103 patients are set out in Table I. It can be seen that there were
no major differences between the males and females as regards
mean ages and body mass indices; 45 patients (44%) were over-













TABLE I. MEAN AGES AND BODY MASS
INDICES OF MI SURVIVORS
Males Females
(96) (7)
Age (yrs) 45,2 47,3
(20 - 55) (42 - 55)
Body mass index 24,7 26,4

























Regardless ofvarying diagnostic classification, abnormal glucose
tolerance is a well-documented risk factor. 16 Abnormalities in
Because of the small number of female MI survivors, the effect
of obesity and abnormal glucose tolerance on lipid levels was
studied in the male patients only. There was no significant
correlation between body mass index and triglycerides (r = 0,03;
P> 0,05) or between body mass index and cholesterol (r = 0,11;
P> 0,05). However, there was a significant inverse correlation
between body mass index and HDL cholesterol (r = -0,22;
P< 0,05).
In Table IV lipid levels in male MI survivors with normal
glucose tolerance and in those with abnormal glucose tolerance
are compared. There was no significant difference between these
two subgroups as regards total cholesterol and HDL cholesterol
levels (P> 0,05); however, triglyceride levels were significantly












Impaired glucose tolerance was present in 14 patients (14%)
and diabetes mellitus was diagnosed in a further 42 (41 %). A total
of 55% (56 patients) of the entire group therefore had abnormal
glucose tolerance (impaired glucose tolerance and diabetes
mellitus).
Comparisons ofthe results of lipid analyses in controls and MI
survivors were undertaken separately for males and females.
Total plasma cholesterol, triglyceride and HDL cholesterol le-
vels for male and female MI survivors compared with those in
controls are shown in Tables 11 and Ill. As can be seen from
these tables, cholesterol and triglyceride levels in male MI survi-
vors (6,99 ± 0,15 mm01l1 and 2,36 ± 0,13 mm01l1 respectively)
and in females (7,0± 0,57 mm01l1 and 2,89 ± 0,73 mmol/l) were
significantly higher than those in controls (5,56 ± 0,13 mm01l1
and 1,63± 0,16 mm01l1 in males; 5,21 ± 0,39 mm01l1and 1,22±
0,10 mmol/l in females). There was no significant difference
between the HDL cholesterol levels in the female patients and
controls. However, male patients had significantly lower HDL
cholesterol levels (0,83 ± 0,02 mm01l1) than male controls (0,95
± 0,03 mm01l1).
Using the cut-off points of 6,5 mm01l1 for cholesterol and 2,0
mm01l1 for rriglycerides 13 it was found that 62% of our patients
had hypercholesterolaemia and 53% hyperrriglyceridaemia;
combined hyperlipidaemia (hypercholesterolaemia and hyper-
triglyceridaemia) was present in 37% of the patients. These
findings contrasted sharply with those in the control group
(hypercholesterolaemia 17%; hypertriglyceridaemia 19% and
combined hyperlipidaemia 10%).
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TABLE IV. COMPARISON OF LIPID LEVELS IN MALE




cant relationship between body mass index and cholesterol and
triglyceride levels.
Hyperlipidaemia is frequently associated wirh diabetes and is
often considered a major determinant of its arherosclerotic
sequelae. The commonest lipid abnormality is hypertriglyceri-
daemi'a,20 but hypercholesterolaemia21 has also been reported.
Information on HDL cholesterol levels in the diabetic state is
somewhat conflicting.22 Since 55% of our patients had abnormal
glucose tolerance, the interrelationship of rhis disorder with
cholesterol, triglyceride and HDL cholesterol levels is of rele-
vance. The finding of significantly higher triglyceride levels in
our patients wirh abnormal glucose tolerance rhan in subjects
wirh normal glucose tolerance would suggest rhat the.abnormal
glucose tolerance contributes significantly to the higheftriglyce-
ride levels in our patients with CAD.
The fact that total cholesterol levels and HDL diolesterol
levels were similar in the two subgroups would suggest rhat rhese
variables are apparently independent of glycaemic starus.
This study has demonstrated that abnormal glucose tolerance,
hyperlipidaemia and low HDL cholesterol levels are significant



































carbohydrate metabolism have been described in approximately
60% of patients with CADY Our results show that 55% of
patients who had had an MI had abnormal glucose tolerance.
This is consistent with the findings of Thandroyen er al. 9 (47%)
and McKechnie lO (53%) and with the published data.
The association between hyperlipidaemia and CAD is well
established. I In previous studies oflipid abnormalities in Indian
patients with CAD arbitrary cut-off points were used to define
hyperlipidaemia.9•lD The Framingham srudyl suggested that rhe
serum cholesterol level is related to risk of CAD as a continuous
function. In an angiographic srudy of patients with and wirhout
CAD Coho er al. 18 were unable to establish any critical serum
level for either cholesterol or triglycerides which would separate
risk from non-risk. In a similar study Gotto er al. 19 concluded
that it was misleading to define hyperlipidaemia using arbitrary
cut-off values. .
Without defining hyperlipidaemia, the present srudy shows
that both cholesterol and triglyceride levels in Indians who had
had an MI were significantly higher than those in a control
group. This finding was also clearly demonstrated when using
arbitrary criteria for rhe definition of hyperlipidaemia. This was
done in order to compare our results wirh those of previous
investigators.9•lD Hypercholesterolaemia was present in 62% of
our patients, a prevalence similar to that reponed by Than-
droyen er al. 9 (63%) but much higher rhan rhat reported by
McKechnie lo (37%). Hypertriglyceridaemia was present in 53%
of our patients, also a prevalence similar to· rhat reported by
Thandroyen er al. (47%); in McKechnie's series triglyceride le-
vels were not measured. However, it should be stressed that
neither of these workers used normal Indian controls for
comparison.
The role of HDL cholesterol in CAD has been examined
extensively.4.5 1t is generally rhought rhat HDL cholesterol levels
are lower in subjects with CAD than in controls. The difference
is often small, but is statistically significant and independent of
orher risk factors. Our fmdings in male patients are in keeping
with this general trend (this relationship was not seen in the
female patients, possibly because of the small number srudied).
Furthermore, rhe significant negative correlation between HDL
cholesterol and body mass index is in accordance wirh previously
published literature.4However, it seems that there is no signifi-
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